Heron Therapeutics, a San Diego biotechnology company that makes cancer and pain-management therapies, is cutting a quarter of its workforce and taking measures to save money.
The goal is to run a lean operation that can achieve profitability in late 2024, according to Mondays announcement. The latest cost-saving measures are projected to save the company approximately $75 million through 2025.
The restructuring is the result of an internal review of the business by its new management team. Heron Therapeutics did not respond to the Union-Tribunes request for comment.
While making some of these decisions was difficult, I believe they are necessary to better position Heron for a sustainable future, said CEO Craig Collard in the announceme…
Read the full article at: https://www.sandiegouniontribune.com/business/story/2023-07-24/heron-therapeutics-cuts-25-percent-of-workers-and-restructures-business-to-sustain-the-company